Last reviewed · How we verify
Antimicrobial agent
Antimicrobial agents work by inhibiting bacterial cell wall synthesis, protein synthesis, or interfering with essential bacterial processes.
Antimicrobial agents work by inhibiting bacterial cell wall synthesis, protein synthesis, or interfering with essential bacterial processes. Used for Bacterial infections.
At a glance
| Generic name | Antimicrobial agent |
|---|---|
| Also known as | Antibiotics |
| Sponsor | Universidad Miguel Hernandez de Elche |
| Drug class | Antimicrobial agent |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 2 |
Mechanism of action
Antimicrobial agents can target various bacterial processes, including cell wall synthesis, which is crucial for bacterial growth and division. By inhibiting these processes, antimicrobial agents can effectively kill or inhibit the growth of bacteria, leading to the resolution of infections.
Approved indications
- Bacterial infections
Common side effects
- Nausea
- Diarrhea
- Vomiting
Key clinical trials
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children (NA)
- Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- A Study of Doxycycline to Treat Chlamydial Infection (PHASE4)
- Arthrosemid vs. Steroid for the Management Knee Osteoarthritis (PHASE4)
- Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (PHASE2)
- Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antimicrobial agent CI brief — competitive landscape report
- Antimicrobial agent updates RSS · CI watch RSS
- Universidad Miguel Hernandez de Elche portfolio CI